GOAL.MD review
Value Score81/100
GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing
We earn a commission when you start treatment through some links on this site, at no extra cost to you. CoreAge Rx is a featured partner, and providers we work with may appear first. It never changes the Value Score.
Advertised price
$179/mo
How much does GOAL.MD cost?
The price GOAL.MD publishes is $179/mo. Tirzepatide is listed at From $249/mo (starting dose, compounded). That rate holds after the first month — there is no step-up we can find. That works out about 49% under the $349/mo brand-name self-pay price for Wegovy.
- Semaglutide
- $179/mo
- Tirzepatide
- From $249/mo (starting dose, compounded)
- Coverage
- All 50 states
- Brand-name
- Yes
The Value Score card
GOAL.MD scored on our six published factors. See the methodology.
Why it's a deal
- Transparent dose-tiered pricing on brand pens
- LegitScript Certified
- Manual-renewal model — no surprise auto-billing
- Free nutrition coach included
- BBB A+ rating since 2021
Read the fine print
- No named compounding pharmacy partner
- Co-founder and chief physician has a 2016 federal guilty plea for distributing misbranded HGH and a (reinstated) license revocation
- No URAC or PCAB pharmacy accreditation
The bottom line
Best for: Shoppers who want manual-renewal billing with dose-tiered brand-name pricing transparency.
For comparison, see CoreAge Rx, a featured partner (Value Score 81/100).
Programs to compare
Compare with other deals
The programs scoring closest to GOAL.MD, out of 428 others we track.
Shopping GOAL.MD against a specific rival? We put it head to head with our featured partner on CoreAge Rx vs GOAL.MD, and every program that undercuts or outscores it — starting with boostAGErx, the closest match on score — is ranked on the GOAL.MD alternatives ranking.
- From $95/moboostAGErx— boostAGErx is a longevity-focused telehealth brand offering compounded GLP-1 weight management (semaglutide and tirzepatide) starting around $95/mo on a 12-month upfront plan, plus peptide therapy.81/100
- From $199/moCurex— Curex is primarily an allergy-immunotherapy company that also runs a GLP-1 line, selling compounded semaglutide and tirzepatide as injections or oral tablets from $199 a month with no membership fee.81/100
- From $117/moEverSlim— EverSlim is a US telehealth program offering doctor-prescribed, compounded GLP-1 weight-loss medication delivered to your door.81/100
- From $79/moGood Girl Rx— Good Girl Rx (Good Girl LLC) offers compounded semaglutide and tirzepatide in injectable, microdose, and oral dissolving tablet (ODT) formats.81/100
- From $149/moRivo Health— Rivo Health is a large nationwide GLP-1 telehealth program (115,000+ members, Trustpilot 4.7) offering compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo.81/100
- From $119/moTrillium Meds— Trillium Meds is a small, owner-operated telehealth platform based in Portland, OR that connects patients with independent licensed providers and FDA-registered compounding pharmacies.81/100
More programs we track (24)
- Tyde Wellness83
- Precision Telemed83
- Telos Rx83
- Lean Meds83
- Sesame Care82
- Enhance MD82
- Fifty 41082
- Tuyo Health82
- Vytora Health82
- EdgeRx82
- CoreAge Rx81
- Bodi Envi81
- Alan Meds81
- Renlo Health81
- Shed80
- Ivologist80
- KERNX Health80
- Queen RX80
- Revel RX80
- Semaglutide Online80
- Zera Health80
- Care Clinics80
- Pepti80
- Lttl79
395 more are reviewed too — see every GLP-1 program we track, ranked.
Pricing and coverage on this page come from GOAL.MD's own website; the Value Score is our editorial judgment per the methodology."% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on GOAL.MD's site. Not medical advice; see our disclosure.